Earth Alive Defendant in Litigation

Cleantech Investing

Earth Alive Clean Technologies (CSE:EAC) has announced it has been served with a motion of legal proceedings from the former CEO, David Gilmour, currently a member of the board of directors. As quoted in the press release: Mr. Gilmour is seeking to be reinstated in his former role and be paid retroactively his full salary …

Earth Alive Clean Technologies (CSE:EAC) has announced it has been served with a motion of legal proceedings from the former CEO, David Gilmour, currently a member of the board of directors.
As quoted in the press release:

Mr. Gilmour is seeking to be reinstated in his former role and be paid retroactively his full salary with benefits or in the alternative, to be compensated for his loss of revenues and paid the sum of $5,000,000 for his shares in the Corporation.
Earth Alive will vigourously defend such claim and will seek to have the Board of directors unanimous decision confirming the nomination of Mr. Michael Warren as President & Chief Executive Officer, taken in good faith and with a view of the Corporation’s best interest, upheld.
On behalf of the Board, Chairman Robert Blain, stated : « We are quite disappointed by Mr. Gilmour’s recent actions seeking to further his own interests to the detriment of the Corporation and its stakeholders. All directors, elected by the Corporations’s shareholders at the recent meeting held in June of 2017, have been consistenly guided by their duty to act and serve the Corporation’s interests. Attempting to circumvent the board decisions with judicial proceedings not only undermines the powers of the duly elected Board and their oversight role, it seeks to shield Mr. Gilmour from any accountability associated to his performance.»
As announced in the press release issued August 30th 2017, management was in discussions with several parties to ensure that Earth Alive’s short term financial needs were met however, under the circumstances, such discussions have been jeopardized due to the pending litigation.

Click here to read the full press release.

The Conversation (0)
×